CAMPSQ1143
Title : Pexiganan
Source : Synthetic construct
PubMed : 10103181
Activity : Antibacterial
Gram Nature : Gram +ve, Gram -ve
Target :
Staphylococcus aureus ATCC 29213 ( MIC = 8 16 microg/ml ), Staphylococcus aureus ATCC 33591 (methicillin resistant) ( MIC = 16 32 microg/ml ), Staphylococcus epidermidis ATCC 12228 ( MIC = 2 4 microg/ml ), Enterococcus faecium ATCC 51559 (vancomycin resistant) ( MIC = 8 microg/ml ), Enterococcus faecalis ATCC 29212 ( MIC = 64 microg/ml ), Group A Streptococcus ATCC 49399 ( MIC = 4 microg/ml ), Streptococcus pneumoniae ATCC 49619 ( MIC = 32 microg/ml ), Streptococcus bovis ATCC 49133 ( MIC = 4 microg/ml ), Bacillus cereus ATCC 11778 ( MIC = 8 microg/ml ), Micrococcus luteus ATCC 4698 ( MIC = 2 microg/ml ), Corynebacterium group A ATCC 49676 ( MIC = 2 4 microg/ml ), Escherichia coli ATCC 25922 ( MIC = 8 16 microg/ml ), Enterobacter cloacae ATCC 35030 ( MIC = 8 microg/ml ), Proteus mirabilis ATCC 29245 ( MIC = >256 microg/ml ), Serratia marcescens ATCC 8100 ( MIC = >256 microg/ml ), Helicobacter pylori ATCC 43504 ( MIC = 2 microg/ml ), Haemophilus influenzae ATCC 49247 ( MIC = 8 microg/ml ), Pseudomonas aeruginosa ATCC 27853 ( MIC = 8 16 microg/ml ), Bacteroides fragilis ATCC 90028 ( MIC = 2 4 microg/ml ), Bacteroides thetaiotaomicron ATCC 29741 ( MIC = 2 4 microg/ml ), Clostridium difficile ATCC 43255 ( MIC = 4 microg/ml ), Propionibacterium acnes ATCC 29399 ( MIC = 8 microg/ml ), Veillonella parvula ATCC 10790 ( MIC = 8 microg/ml )
Validated : Experimentally validated
Length : 22
Sequence:
GIGKFLKKAKKFGKAFVKILKK

| © 2022, Biomedical Informatics Centre, ICMR-NIRRCH |
ICMR-National Institute for Research in Reproductive and Child Health, Jehangir Merwanji Street, Parel, Mumbai-400012
Maharashtra, India